Thermo Fisher Scientific (FRA:TN8) Accounts Payable: €0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TN8 Thermo Fisher Scientific Inc FRA:TN8
83 GF Score
Price €490.60
GF Value €510.40
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Thermo Fisher Scientific Accounts Payable?

Thermo Fisher Scientific FRA:TN8 -2.50% 83 Accounts Payable is €0 Mil as of Jun. 2026. GuruFocus rates FRA:TN8 with a GF Score™ of 83/100 and a GF Value™ of €510.40 (Fairly Valued). The stock has 8 warning signs investors should review.

Thermo Fisher Scientific's Accounts Payable for the quarter that ended in Jun. 2026 was €0 Mil.

Thermo Fisher Scientific's quarterly Accounts Payable declined from Dec. 2025 (€3,093 Mil) to Mar. 2026 (€2,893 Mil) and declined from Mar. 2026 (€2,893 Mil) to Jun. 2026 (€0 Mil).

Thermo Fisher Scientific's annual Accounts Payable increased from Dec. 2023 (€2,634 Mil) to Dec. 2024 (€2,940 Mil) and increased from Dec. 2024 (€2,940 Mil) to Dec. 2025 (€3,093 Mil).

Thermo Fisher Scientific Accounts Payable Related Terms

Thermo Fisher Scientific Accounts Payable Historical Data

* Premium members only.

The historical data trend for Thermo Fisher Scientific's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thermo Fisher Scientific Accounts Payable Chart

Thermo Fisher Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,537.30 3,191.66 2,633.62 2,940.45 3,093.19

Thermo Fisher Scientific Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,583.66 2,658.24 3,093.19 2,892.56 0.00
FRA:TN8
83GF Score
Thermo Fisher Scientific Inc FRA:TN8
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thermo Fisher Scientific Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €0 Mil mean?
Thermo Fisher Scientific (FRA:TN8) has a Accounts Payable of €0 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Thermo Fisher Scientific and its competitors.
Is Thermo Fisher Scientific's Accounts Payable too high?
Thermo Fisher Scientific's current Accounts Payable is €0 Mil. Overall, Thermo Fisher Scientific has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's Accounts Payable compare to DHR and IDXX?
Thermo Fisher Scientific's Accounts Payable of €0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Diagnostics & Research company?
A good Accounts Payable depends on the Medical Diagnostics & Research industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Thermo Fisher Scientific and its competitors. Thermo Fisher Scientific's current Accounts Payable is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (FRA:TN8) is currently considered Fairly Valued. The stock's GF Value™ is €510.40, compared to a current price of €490.60 — trading 3.9% below its estimated fair value. The current Accounts Payable is €0 Mil. Thermo Fisher Scientific's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Thermo Fisher Scientific (FRA:TN8), the current Accounts Payable is €0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thermo Fisher Scientific (FRA:TN8) Overvalued in 2026?

Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued. The current stock price of €490.60 is trading 3.9% below its estimated GF Value™ of €510.40. GuruFocus considers Thermo Fisher Scientific to be Fairly Valued.

Key valuation signals for FRA:TN8:

  • Accounts Payable: €0 Mil
  • GF Value™: €510.40 vs. price of €490.60 (3.9% below fair value)
  • GF Score™: 83/100 with 8 warning signs

No single metric tells the full story. See the FRA:TN8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Thermo Fisher Scientific Business Description

Address 168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
83GF Score

Get the complete analysis for FRA:TN8

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€490.60
Price
€510.40
GF Value